Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of rate gouging, declaring the stark distinction in between U.S. price ranges and people in Europe and copyright.Even so, It really is crucial to stay aware that these price savings mightn't implement universall